Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Ruling on antibiotics in livestock reversed
24 Jul 2014 at 1:57pm
NEW YORK (AP) ? The U.S. Food and Drug Administration isn't required to hold public hearings to evaluate the health risks of widespread use of antibiotics in animal feed, a federal appeals court ruled Thursday.


Varying health premium subsidies worry consumers
24 Jul 2014 at 10:39am

MIAMI (AP) ? Linda Close was grateful to learn she qualified for a sizable subsidy to help pay for her health insurance under the new federal law. But in the process of signing up for a plan, Close said her HealthCare.gov account showed several different subsidy amounts, varying as much as $180 per month.


China lifts quarantine after man dies of plague
23 Jul 2014 at 10:27pm
BEIJING (AP) ? A nine-day quarantine imposed on parts of a northern Chinese city where a man died of bubonic plague has been lifted, China's official news agency reported Thursday.

WHO seeks humanitarian corridor to evacuate Gaza wounded
25 Jul 2014 at 7:00am
The World Health Organisation (WHO) called on Friday for a humanitarian corridor to be set up in Gaza to allow aid workers to evacuate the wounded and bring in life-saving medicines. WHO officials have discussed the proposal with both Israeli and Egyptian officials, but there has been no response yet, WHO spokesman Paul Garwood said. U.S. Secretary of State John Kerry pressed regional proxies to agree on a Gaza ceasefire on Friday as the death toll soared to over 800. In a statement, the U.N. health agency said that it was difficult for the sick and wounded to get access to health care and that some needed to leave the coastal strip for treatment.

U.S. meat, seafood prices rising on drought and disease: USDA
25 Jul 2014 at 6:56am
By Ros Krasny WASHINGTON (Reuters) - Overall U.S. food inflation will remain near the historic norm in 2014, even as prices for meat and seafood are pushed higher by disease and widespread drought, the U.S. Department of Agriculture said on Friday. USDA said wholesale pork prices will jump by 10 percent to 11 percent in 2014, hurt by declining supplies after a virus has killed millions of piglets in the past year. Food inflation, which includes items bought in grocery stores as well as in restaurants, will rise by 2.5 percent to 3.5 percent this year and subside to 2 percent to 3 percent in 2015, the USDA said in its first forecast for the new year. The agency noted a recent jump in vegetable prices but said it was too soon to tie the move to the severe drought in California, the largest U.S. grower of fruits and vegetables.


Bayer says Nexavar fails in breast cancer study
25 Jul 2014 at 6:37am

FRANKFURT (Reuters) - German drugmaker Bayer said a Phase III trial of cancer drug Nexavar in patients with advanced breast cancer did not meet its primary endpoint of delaying the progression of the disease. The study, called Resilience, evaluated Nexavar in combination with chemotherapeutic agent capecitabine, in women with HER2-negative breast cancer. Oral drug Nexavar, which Bayer is developing jointly with Amgen, is approved for use against certain types of liver, kidney and thyroid cancer. Study details are expected to be presented at an upcoming scientific conference. ...



Liberian with Ebola-like symptoms dies in Nigeria: official
25 Jul 2014 at 6:28am

A Liberian man hospitalised in Lagos with Ebola-like symptoms has died, an official said Friday, without confirming the virus was the cause of his death. The 40-year-old Monrovia resident arrived in Nigeria's mega-city on Sunday and was admitted to hospital after suffering from severe vomiting and diarrhoea. "The Liberian man has died," said a source with the Lagos state health ministry who requested anonymity. The patient's blood samples have been sent to a lab in Lagos and the World Health Organization in Dakar.


Report Raises Safety Questions on Popular Blood Thinner
25 Jul 2014 at 6:18am
Pradaxa has been linked to bleeding complications.

First Ebola victim in Sierra Leone capital on the run
25 Jul 2014 at 6:17am
By Umaru Fofana FREETOWN (Reuters) - Sierra Leone officials appealed for help on Friday to trace the first known resident in the capital with Ebola whose family forcibly removed her from a Freetown hospital after testing positive for the deadly disease. Radio stations in Freetown, a city of around 1 million inhabitants, broadcast the appeal on Friday to locate a woman who tested positive for the disease that has killed 660 people across Guinea, Liberia and Sierra Leone since an outbreak was first identified in February. "Saudatu Koroma of 25 Old Railway Line, Brima Lane, Wellington," the announcement said. We need the public to help us locate her." Koroma, 32, a resident of the densely populated Wellington neighbourhood, had been admitted to an isolation ward while blood samples were tested for the virus, Health ministry spokesman Sidi Yahya Tunis.

India battles to contain 'brain fever' as deaths reach almost 570
25 Jul 2014 at 6:13am
By Nita Bhalla NEW DELHI (Thomson Reuters Foundation) - Almost 570 people in India have died after contracting encephalitis, commonly known as "brain fever", health authorities said on Friday, warning the death toll may rise with more people still at risk. Outbreaks of Acute Encephalitis Syndrome and Japanese Encephalitis are common every year in India, especially during the monsoon season, and claim hundreds of lives. In West Bengal, where at least 111 people have died from both strains, a senior health official said authorities were taking emergency steps to contain the outbreak.


West Africa Ebola death toll reaches 660: WHO
25 Jul 2014 at 6:13am

The death toll in West Africa's Ebola outbreak has risen to 660, with the number of cases surpassing 1,000, the World Health Organization said Friday. WHO spokesman Paul Garwood said that the extent of what is the deadliest outbreak of Ebola on record was still emerging. Thirteen were in Sierra Leone, 11 in Liberia and four in Guinea, which had previously borne the brunt. Forty-five new cases were recorded over the same period, in West Africa's first-ever Ebola outbreak.


What Not To Say To Someone Who Doesn't Drink
25 Jul 2014 at 5:20am



Novo wins EU recommendation for two-in-one diabetes drug
25 Jul 2014 at 5:15am

By Ben Hirschler LONDON (Reuters) - A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza has been recommended for approval in Europe, in an important boost for the Danish company. The European Medicines Agency said on Friday it had issued a positive opinion for Xultophy, previously known as IDegLira, implying the medicine is likely to be formally approved by the European Commission within three months. Novo said it planned to launch Xultophy in the first European markets in the first half of 2015. Jakob Riis, executive vice president of marketing and medical affairs at Novo Nordisk, said Britain, Germany and Denmark were likely to be among the first launch markets for the product.


Novo sees two-in-one diabetes drug in Europe in first half of 2015
25 Jul 2014 at 4:46am
Novo Nordisk, the world's largest insulin maker, said on Friday it expected European Commission marketing authorization for its new two-in-one insulin drug within three months after an EU medicines agency recommended the drug. It said subject to the EU Commission approval and the completion of pricing and reimbursement discussions, it expected to have the drug out into the first European markets by the first half of 2015.


Town 'sealed off' after man dies of plague in China
25 Jul 2014 at 4:09am

A Chinese town has been sealed off and 151 people placed in quarantine since last week after a man died of bubonic plague, state media said Tuesday. The 30,000 people living in Yumen in the northwestern province of Gansu are not being allowed to leave, and police at roadblocks on its perimeter are telling motorists to find alternative routes, the television arm of the official news agency Xinhua said.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC